Library

Compare substances

Side-by-side comparisons with mechanism, dose, half-life, evidence, safety, and legal status. Curated launch set; Phase 2 expands to 60+ pairs.

Eugeroic vs. classic stimulant — onset, duration, abuse potential, and crash profile.

The most-studied synergy pair. Why 1:2 is the canonical ratio.

Two best-in-class choline sources. Bioavailability, secondary effects, cost.

The original vs. the anxiolytic upgrade. Solubility, dose, profile differences.

Slow-build adaptogen vs. acute AChE inhibitor for memory.

Two amino acid heavyweights with overlapping neuroprotective profiles.